Intervention

diet

ClinicalTrials.gov intervention label

Clinical trials17
Recruiting0
Common conditions18
Lead sponsors shown15

Clinical trials

17 shown
Border Region Area Lifestyle Intervention Study for Healthy Neurocognitive Ageing DiabetesNCT05304975 · 2021-11-01
COMPLETED
Hunger and Learning Study in PreschoolersNCT03861208 · 2018-07-01
COMPLETED
Prevention of Maternal and Fetal Metabolic Complications With Diet and Nutraceutical Supplementation in Pregnant Women Affected by Gestational Diabetes: a Randomized, Double-blind Placebo Controlled Trial.NCT05393843 · 2018-05-01
TERMINATED
The Effect of Type 2 Diabetes and Dietary Regulation on VLDL1-and VLDL2-triglyceride MetabolismNCT01564550 · 2012-11-01
COMPLETED
GLP-1 and Microvascular Function in Type 2 DiabetesNCT01740921 · 2011-01-01
COMPLETED
Low Energy Dense, Weight Maintenance, Risk of Cardiovascular DiseaseNCT01659450 · 2011-01-01
COMPLETED
Tissue Composition of Newborn Infants of Obese and Lean MothersNCT01235676 · 2010-02-01
COMPLETED
Study of the Role of PCSK9 and FXR in the Physiopathology of the Joint Dyslipidemia Associated to the Human ImmunoresistanceNCT00422006 · 2008-02-01
COMPLETED
Using the Energy Gap to Prevent Weight RegainNCT00429650 · 2007-07-01
COMPLETED
Changing Eating Behaviors in Young Children: Should Healthy Foods be Increased or Unhealthy Foods Decreased?NCT00200265 · 2005-07-01
COMPLETED
The Role of Exercise and Diet in Weight Loss in Obese ChildrenNCT00461994 · 2004-04-01
COMPLETED
Cafeteria-Based Study of Weight Gain PreventionNCT00142662 · 2002-09-01
COMPLETED
Adherence to Weight Loss for Hypertension in African American WomenNCT00142649 · 2002-09-01
COMPLETED
Enhancing Support for Women at Risk for Heart DiseaseNCT00142701 · 1999-04-01
COMPLETED
PATHWAYS--FULL SCALE STUDYNCT00000545 · 1993-09-01
COMPLETED
Insulin Resistance and Insulin SecretionNCT00073294
WITHDRAWN
Effectiveness of Atkins Diet for Weight LossNCT00006193
UNKNOWN

Leading sponsors

Trial status mix

COMPLETED14
TERMINATED1
UNKNOWN1
WITHDRAWN1

Phase mix

NA13
PHASE21
PHASE31
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.